NDA SUPPLEMENT REVIEWS ARE TOPIC FOR DISCUSSION BETWEEN PMA AND FDA; PMA REGULATORY AFFAIRS EXECS TO PROPOSE PLAN FOR "MEDICAL" SUPPLEMENTS